176 results

• Generic Avapro (Irbesartan) Recall Issued Over Cancer Risks From Manufacturing Impurities

  October 31, 2018

  Irvin Jackson

  The FDA announced a recall of some irbesartan products due to cancer-causing impurities similar to those responsible for a number of recent valsartan recalls.

• MDL Sought for Valsartan Recall Lawsuits Over NDMA Contamination

  October 30, 2018

  Austin Kirk

  A plaintiff has called for all federal valsartan lawsuits to be consolidated before one judge for pretrial proceedings.

• List of Recalled Valsartan Drugs Expanded Again Over NDMA Cancer Concerns

  October 26, 2018

  Irvin Jackson

  The FDA has expanded the valsartan recall, pulling additional tablets made by an Indian manufacturer which tested positive for cancer-causing impurities.

• Valsartan Lawsuit Claims Consumers Should Be Reimbursed For Buying Contaminated Drugs

  October 22, 2018

  Irvin Jackson

  A new valsartan class action lawsuit says that consumers deserve to be reimbursed for purchasing useless generic drugs which had to be recalled due to the risk they were contaminated with cancer-causing impurities.

• Valsartan Shortage Following Recall Results in Rise in Drug Prices

  October 19, 2018

  Irvin Jackson

  A new report indicates that the cost of commonly used valsartan tablets doubled from August to September due to a shortage caused by the recent recalls.

• FDA Issues Warning Letter To South Korean Drug Manufacturer Over Sterility Concerns

  October 18, 2018

  Irvin Jackson

  The FDA sent a warning letter to a South Korean drug manufacturer threatening to ban its products for the second time this year over manufacturing deficiencies.

• Class Action Lawsuit Filed Over Generic Valsartan Recalled Due to Known Carcinogen Impurity

  October 17, 2018

  Irvin Jackson

  A valsartan class action lawsuit says consumers were cheated by being sold sub-par generic drugs that were eventually recalled due to cancer-causing impurities.

• Valsartan Recall Letters Sent By Health Insurance Companies, Pharmacies

  October 12, 2018

  Irvin Jackson

  A number of insurance companies and pharmacies are warning customers that more valsartan recalls could be on the way as the FDA continues to investigate the presence of cancer-causing impurities in the hypertension drugs.

• Valsartan Manufacturing Problems Lead to Lawsuits, Ban on Imports from Chinese Pharma Company

  October 8, 2018

  Irvin Jackson

  The FDA has banned drug products from a Chinese manufacturer linked to massive valsartan recalls.

• Class Action Over Recalled Valsartan Targets Walmart, CVS, Kroger, Other Retailers Over Selling NDMA-Tainted Drugs

  October 2, 2018

  Irvin Jackson

  A class action lawsuit seeks compensation for all those who purchased recalled valsartan hypertension tablets and now cannot use them due cancer-causing impurities.